Glycoscience moves from the laboratory to the clinic.
Rowe
P M
PM
D017485:1-Deoxynojirimycin / Q000737:chemistry / Q000627:therapeutic use* / Q000031:analogs & derivatives; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000627:therapeutic use*; D019380:Anti-HIV Agents / Q000737:chemistry / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000737:chemistry / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000627:therapeutic use*; D005944:Glucosamine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D013329:Structure-Activity Relationship; D017026:Swainsonine / Q000737:chemistry / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D019380:Anti-HIV Agents; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D017485:1-Deoxynojirimycin; D005944:Glucosamine; D017026:Swainsonine; C013626:nojirimycin